Log In
Print this Print this

BART (BRAC analysis large rearrangement test)

  Manage Alerts
Collapse Summary General Information
Company Myriad Genetics Inc.
DescriptionPredictive test for detecting large genomic rearrangements in the genes involved in hereditary breast and ovarian cancer patients
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsPredict test for breast and ovarian cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today